Table IV.
95% CI
|
|||
---|---|---|---|
Characteristic | Risk estimate | Lower | Upper |
Male gender | 0.944 | 0.334 | 2.670 |
Age ≥40 years | 0.762 | 0.250 | 2.319 |
Disease duration ≥4 years | 0.514 | 0.177 | 1.491 |
Seo’s CIDAI ≥220 points | 1.083 | 0.386 | 3.044 |
Prior AZA treatment | 2.105 | 0.648 | 6.835 |
Undermining ulcer present | 0.711 | 0.255 | 1.981 |
Pancolitis | 2.403 | 0.788 | 7.335 |
C7-HRP positivity | 3.529 | 1.051 | 11.855 |
PSL ≥10,000 mg | 3.972 | 1.091 | 14.467 |
CNI non-responder | 19.833 | 3.950 | 99.590 |
Values in bold print are statistically significant. AZA, azathioprine; CIDAI, complex integrated disease activity index; CI, confidence interval; CNI, calcineurin inhibitor; PSL, prednisolone.